Abstract
Introduction
The marine environment represents a rich source of novel natural products with great potential for drug discovery. Recent reviews on marine natural products have revealed that marine-derived natural products produce some of the most promising bioactive compounds (Newman and Cragg, 2004; Newman, 2008) . Many marine invertebrates and algae have a long evolutionary history and reside in highly competitive and harsh environments. In order to survive such environments, they have developed defence systems (Sipkema et al., 2005) for protection, often in the form of toxic or deterrent chemicals. In recent years, extraction, isolation and characterization of these chemicals has led to the discovery of some of the most promising drug candidates.
Over the years many organisms (such as sponges, algae, bacteria, fungi, soft corals and gorgonians, sea hares and nudibranchs, bryozoans and tunicates) have been studied for their bioactive compounds (Faulkner, 2000) . Hundreds of new bioactive compounds with a wide range of activity including antitumor, antibacterial and antifungal amongst others are discovered annually from these organisms with sponges dominating as the major contributing phyla (Blunt et al., 2007) . Currently a number of compounds of marine origin are being investigated and developed as new pharmaceuticals including ecteinascidin 743, discodermolide, salinosporamide A, the pseudopterosins and the bryostatins. Many more are either currently in clinical trials or are incorporated into commercial products (Newman and Cragg, 2004; Newman, 2008) .
For a number of years, scientists at the University of the South Pacific (USP) have conducted research on natural products from Fijian marine invertebrates for potential lead compounds that could be developed into pharmaceutical drugs (Feussner et al., 2012) . In accordance with the USP's vision of engaging with the region, an expedition focusing on the collection of marine invertebrates and algae for drug discovery efforts was conducted in Vanuatu in 2008. The present work involves samples collected from Vanuatu, a biodiversity hotspot with an attractive marine fauna. Previous collections in Vanuatu by marine natural products research groups have resulted in the discovery of many interesting marine derived natural products. Renieramide, a cyclic tripeptide which showed immunomodulating activity in preliminary tests was isolated from the polar extract of the Vanuatu sponge Reniera n. sp. (Ciasullo et al., 2002) . Antiproliferative cyclopeptides, axinellins A and B, which exhibited moderate in vitro antitumor activity against human bronchopulmonary cell lines, were isolated from the sponge Axinella carteri (Randazzo et al., 1998) . Numerous other bioactive products have been isolated including the sponge derived crellastatins (D'Auria et al., 1998; Zampella et al., 1999) and callipeltins (Sepe et al., 2006; Zampella et al., 2002) . Recently, four new tris-bromoindole cyclic guanidine alkaloids, araiosamines A-D, were isolated from the marine sponge, Clathria (Thalyasis) araiosa (Wei et al., 2011) . The isolation of these bioactive natural products demonstrates that bioprospecting in Vanuatu can potentially lead to the discovery of new drugs.
This paper reports the screening of selected marine samples with the aim of identifying marine invertebrates and plants that could be investigated further for potential antimicrobial and anticancer drug leads. The marine samples studied included 52 sponges, 5 algae, 17 samples of soft corals (cnidaria) and 5 other marine invertebrates that were screened for antibacterial and antifungal activities. All samples were also tested for their cytotoxic activity by the use of a brine shrimp bioassay, the results of which can be correlated to potential antitumor activity (Anderson et al., 1991) . The results showed that a significant number of marine invertebrates and plants were found to have antimicrobial and cytotoxic activity. The findings of this study could provide promising candidates for further research into antimicrobial and anticancer drug development.
Materials and Methods

Biological Material
The 
Preparation of the Extracts
The organisms, weighing between 50-1000 g (wet weight), were separately thawed and cut into small pieces. The samples were extracted using methanol (2 x 1000 mL) followed by dichloromethane (2 x 1000 mL). The extracts were filtered through Advantec Qualitative filter paper (grade 1, 240 mm) under gravity. The methanol and dichloromethane filtrates were combined and evaporated to dryness under vacuum (30 o C) to give the crude material for screening.
Antimicrobial Assays
The antimicrobial potential of the extracts was determined in a disc diffusion assay employing methicillin-resistant Staphylococcus aureus (MRSA; ATCC 10537), wild type S. aureus (WTSA; ATCC 25923), vancomycin-resistant Enterococcus faecium (VREF; ATCC 12952), amphotericin-resistant Candida albicans (ARCA; ATCC 90873) and wild type C. albicans (WTCA; ATCC 32354) as test organisms to investigate. The handling of the strains took place in the laminar flow hood with the utilization of aseptic techniques.
Preparation of Media
All media were sterilized in the autoclave at 121 °C for 15 mins. Volumes of 10 mL of the thawed bacterial cultures were transferred to separate tubes containing 10 mL of tryptic soy broth (TSB). Vancomycin (100 mL of 10 mg/mL) was added to one of the tubes containing 10 mL of TSB prior to the addition of 10 mL of VREF culture to maintain resistance. Thawed (100 mL) cultures of C. albicans were added to sterilized tubes containing 10 mL of Roswell Park Memorial Institute (RPMI)-medium. The tubes, together with a blank (TSB only), were incubated at 37 °C for 18-20 hrs. The colour change (pink to white) of the RPM1-medium was taken as an indication that the fungal cultures were ready. The bacterial overnight cultures were diluted 100 fold (TSB) in 3 mL cuvettes and optical density was measured at a wavelength of 600 nm in a UV/VIS spectrophotometer (Lambda 3B, Perkin Elmer). The growth densities of bacterial cultures were tested by analyzing the seed cultures in a UV spectrophotometer at 800 nm. The optimum optical density for good growth was detected at a range of 0.1 to 0.3.
Preparation of Assay Plates
The assay plates were prepared by the pour plate method. Three different media were used for the organisms. These include the Nutrient agar (NA; 20 g), Luria Bertani agar (LBA; 36 g) and Potato Dextrose agar (PDA; 35 g) and were suspended in separate 100 mL of distilled water and autoclaved at 121 °C for 15 mins. For MRSA and WTSA, 100 µL of overnight cultures were pipetted into two respective 100 mL NA. For VREF, 100 µL of overnight culture was inoculated into 100 mL LBA media. A 1 mL volume of WTCA and ARCA overnight cultures in RPMI medium were inoculated into 100 mL of PDA. The media were mixed gently, after which 15 -20 mL of agar was poured into (90 x 15 mm) petri dishes, forming a layer of 4-5 mm of agar thickness. This was placed on an even surface and allowed to solidify. To avoid the risk of contaminations, freshly prepared assay plates were used in the experiments.
Sample Preparation and Testing by Disc
Diffusion Method Samples preparation and Disc Difussion method has been followed as previously described by Subramani et al. (2013) . A test solution of the crude (25 mg) was dissolved in 100 L of Dimethylsulfoxide (DMSO) to prepare a concentration of 250 mg/mL. DMSO was selected due to the good solubility of extracts in this solvent. Aliquots of 10 L were transferred onto 6 mm sterilized discs (Becton, Dickinson and Company, USA) placed on a sterile paper in the laminar flow hood. The inoculated discs (sample concentration = 0.25 mg/disc) were left in the laminar flow for an hour to dry. The discs were inverted and placed on the surface of the agar. Rifamycin (50 g), vancomycin (200 g) and nystatin (100 g) were used as positive controls against VREF, WTSA/MRSA, and WTCA/ARCA, respectively. In order to avoid any effect from the solvent, DMSO was also used as the negative control. The plates were wrapped in parafilm and incubated upside down at 37 °C. The diameter of the zones of inhibition was measured (mm) and recorded after 24 hrs of incubation.
Brine Shrimp Test for Cytotoxicity
Brine shrimp (Artemia salina) eggs were hatched for 48 hrs in a beaker containing 300 mL of filtered (0.45 m millipore) sea water (Sam, 1993) . The beaker was aerated with the aid of an air pump and kept at 27±2 °C. The nauplii hatched within 48 hrs under a bright light source. Volumes of 100 L of sea water containing 7-12 brine shrimp larvae were transferred to each well of a 96-well microtiter assay plate.
Stock solutions (25 mg/mL) of the crude extracts were prepared in 10% DMSO/filtered sea water. From this stock solution, concentrations of 2000 ppm, 1000 ppm and 500 ppm concentration were prepared in 1.5 mL Eppendorf tubes. Aliquots of the solutions (100 L) were transferred to each well containing 100 L of sea water and brine shrimp larvae, resulting in a testing concentration of 1000 ppm, 500 ppm, 250 ppm in each of the wells. All the tests were performed in triplicates. A well containing brine shrimps in plain sea water and DMSO served as the negative control with an expected 100% survival rate. If a death rate of more than 50% was observed at 250 ppm, another set of dilutions was carried out up to a final concentration of approximately 2 ppm Tables 1-4 show the results from the antimicrobial assays and the brine shrimp assay (BSA) of the sample extracts and controls used. The results show that highly potent antibacterial and antifungal activity could be detected in some of the extracts. BSA results reveal the toxicity of the extracts, which can be correlated to potential antitumor activity and provide a guide for detection of antitumor compounds (Anderson et al., 1991) .
Results and Discussion
BSA, Antibacterial and Antifungal Activity in
Sponges Table 1 shows the cytotoxicity and antimicrobial results of the sponge extracts used in this study. The BSA results show that a large number of sponges were found to be cytotoxic confirming that they are a prolific source of bioactive compounds. For our analyses, we considered samples with a LD 50 (Lethal Dose at which 50% are dead) of 150 ppm and below to be of a strong bioactivity, and those between 150-500 ppm to be with moderate bioactivity. Samples with values above 500 ppm to 1000 ppm were considered to be weak and those above 1000 ppm, insignificant. Based on this assessment, 33% of sponges tested showed strong activity against brine shrimps and the remaining show either weak or moderate activity. Crella spinulata showed the highest cytotoxicity value of LD 50 = 16 ppm for brine shrimp lethality and can be regarded as a promising lead for marine-derived antitumor compounds. The cytotoxic compounds, Crellastatins have been reported from a Crella sp. collected from Vanuatu (D' Auria et al., 1998) . Corticium sp. was also found to be highly toxic (LD 50 = 25 ppm). Ridley and Faulkner have confirmed the presence of the cytotoxic alkaloid, plakinamine, from this sponge (Ridley and Faulkner, 2003) . Other sponges with strong cytotoxic activities include a Theonella sp, an Axinyssa sp and Dactylospongia elegans as shown in Table 1 . Notably, the antitumor agents Theopederins A-E have been reported from Theonella sp (Fusetani et al., 1992) while Axinyssa sp has been found to produce cytotoxic sesquiterpenes (Petrichtcheva et al., 2002) . Dactylospongia elegans (100 ppm), a sponge that is known to produce smenospongine (Kondracki and Guyot, 1987 ) and dactyl-spongenones (Kushlan et al., 1989) , both strong anticancer agents has also been reported. The bioactivities displayed by these sponge extracts demonstrated that they can provide promising candidates for anticancer drug leads. Crude extracts contain a broad range of compounds which contribute to the overall pharmacological activity seen in a sample. Therefore, the bioactivity observed for these samples indicate that they possess metabolites with significantly potent bioactivity in their pure form. Further studies are needed to confirm if the activity observed is due to new bioactive compounds or known compounds.
All 52 sponges were screened for antibacterial and antifungal activity (Table 1) . Bioactivity was considered based on the inhibition zones displayed by the extracts where a zone of less than 10 mm was considered to be of weak activity, 10-15 mm as being moderate and above 15 mm to be of strong activity. Based on this, a total of 8 sponge samples showed activity against VREF and MRSA, with inhibition zones of 10 mm and above. Phyllospongia sp., Lamellodysidea herbacea and an unidentified sponge of the order Halichondrida showed the highest bioactivities (values ranging from 14-16 mm). It is noteworthy that Phyllospongia spp have been reported to produce sesterterpenes, which are compounds with antimicrobial activity (Bowden et al., 1992; Hanson, 1996) and Lamellodysidea herbacea has been reported to produce polybrominated diphenyl ethers, which are known to have antimicrobial properties (Bowden et al., 1992) . Hippospongia metachromia was found to be the only sponge with bioactivity against VREF with a 12 mm zone of inhibition, a result which is in agreement with a recent report highlighting the presence of VREF active quinones from a Fijian sponge of the genus Hippospongia . The antifungal assay showed two sponges with antifungal activity, the highest value recorded for a Theonella sp. (16 Table 2 shows the results of the BSA, antibacterial and antifungal assays for the algal extracts tested. Weak to moderate bioactivities were recorded for all assays conducted. It is worth mentioning that Peysonnelia cf. enamoena was found to be the only alga with moderate antibacterial activity (10 mm). The same alga also showed cytotoxic activity (LD 50 = 190 ppm). Sterol glycosides, isolated from a Peysonnelia sp., have been reported to show good anticancer activity towards human breast cancer and human lung cancer (Lin et al., 2010) . Table 3 displays the BSA, antibacterial and antifungal results for cnidaria and other invertebrates tested. For cnidaria (Table 3) , 18% of the samples were found to be active against brine shrimps. These include Zoanthus sp., Sinularia sp. 1 and Viminella sp., all showing activity below 150 ppm. Cytotoxic activity has previously been detected in Sinularia sp. in the form of sesquiterpenes (Zhang et al., 2008; Zhang et al., 2006) and crembranoid diterpenes (Li et al., 2005) . No bioactivity has been reported for Viminella sp., however, their defense has been associated with structural rather than chemical mechanisms (Puglisi et al., 2002) . This could indicate new and interesting chemistry for this gorgonian. Antimicrobial activities were found to be weak and negligible for all cnidaria samples tested.
For other invertebrates (Table 4) , weak to moderate cytotoxicity was detected for all samples except for Comanthus sp. 1 which was found to be highly active towards brine shrimp i.e. LD 50 = 95 ppm. Comanthus parvicirrus had been reported to produce naphthopyrones (Folmer et al., 2008) which have been tested for NF-κB, an inducible transcription factor known to play an important role in cancer development and inflammation (Karin, (Chang and Lee, 1985) and the presence of cytotoxic anthraquinones has also been reported from this genus (Ebada et al., 2009) . All other samples in Table 4 showed weak and negligible antimicrobial activities suggesting that they are poor sources of antimicrobial metabolites. Overall, these results are important and useful in that they provide the scientific basis upon which to select potential candidates for further research into antimicrobial and anticancer related studies.
Conclusion
A total of seventy nine marine invertebrate and algae extracts were screened for their bioactivity. Our preliminary results indicate that the extracts proved to be promising sources of antimicrobial and cytotoxic (anticancer) metabolites. Amongst the samples investigated, Crella spinulata was the most promising species screened for anticancer activity. The best candidates for antibacterial leads were the sponges Lamellodysidea herbacea, Phyllospongia sp., a sponge in the order Halichondrida, while the sponge Theonella sp. is the most promising for antifungal leads. Further purification and bioactivity studies of the crude extracts are needed to identify the metabolites responsible for the cytotoxicity, antibacterial and antifungal activity that is shown.
